544
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Epigallocatechin Gallate-Loaded Polysaccharide Nanoparticles for Prostate Cancer Chemoprevention

, , , , &
Pages 79-87 | Published online: 23 Dec 2010

Bibliography

  • Siddiqui IA , AdhamiVM, BharaliDJet al.: Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.Cancer Res.69(5), 1712–1716 (2009).
  • Shutava TG , BalkundiSS, VangalaPet al.: Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols.ACS Nano3(7), 1877–1885 (2009).
  • Aron PM , KennedyJA: Review. Flavan-3-ols: nature, occurrence and biological activity.Mol. Nutr. Food Res.52, 79–104 (2008).
  • Stuart EC , ScandlynMJ, RosengrenRJ: Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.Life Sci.79(25), 2329–2336 (2006).
  • Nair CKK , SalviVP: Protection of DNA from γ-radiation induced strand breaks by epicatechin.Mutat. Res.650(1), 48–54 (2008).
  • Baatout S , JacquetP, DerradjiH, OomsD, MichauxA, MergeayM: Study of the combined effect of x-irradiation and epigallocatechin-gallate (a tea component) on the growth inhibition and induction of apoptosis in human cancer cell lines.Oncol. Rep.12(1), 159–167 (2004).
  • Sugiyama T , SadzukaY: Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.Biochim. Biophys. Acta Rev. Cancer1653(2), 47–59 (2003).
  • Sugiyama T , SadzukaY: Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level.Cancer Lett.212(2), 177–184 (2004).
  • Khan N , AfaqF, SaleemM, AhmadN, MukhtarH: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.Cancer Res.66(5), 2500–2505 (2006).
  • Gupta S , AhmadN, Nieminen A-L, Mukhtar H: Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol.164, 82–90 (2000).
  • Liao S , UmekitaY, GuoJ, KokontisJM, HiipakkaRA: Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.Cancer Lett.96, 239–243 (1995).
  • Gupta S , HastakK, AhmadN, LewinJS, MukhtarH: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea catechins.Proc. Natl Acad. Sci. USA98, 10350–10355 (2001).
  • Su YL , LeungLK, HuangY, Chen Z-Y: Stability of tea theaflavins and catechins. Food Chem.83, 189–195 (2003).
  • Yoshino K , SuzukiM, SasakiK, MiyaseT, SanoM: Formation of antioxidants from (-)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasma.J. Nutr. Biochem.10(4), 223–229 (1999).
  • Chen L , Lee M-J, Li H, Yang CS: Absorption, distribution and elimination of tea polyphenols in rats. Drug Metab. Dispos.25, 1045–1050 (1997).
  • Lambert JD , Lee M-J, Lu H et al.: Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr.133, 4172–4177 (2003).
  • Ratnam DV , AnkolaDD, BhardwajV, SahanaDK, KumarMNVR: Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective.J. Control. Release113, 189–207 (2006).
  • Manach C , WilliamsonG, MorandC, ScalbertA, RémésyC: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.Am. J. Clin. Nutr.81(Suppl. 1), S230–S242 (2005).
  • Nishiyama N : Nanomedicine: nanocarriers shape up for long life.Nat. Nanotechnol.2, 203–204 (2007).
  • Pridgen EM , LangerR, FarokhzadOC: Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.Nanomedicine (Lond.)2(5), 669–680 (2007).
  • Brannon-Peppas L , BlanchetteJO: Nanoparticle and targeted systems for cancer therapy.Adv. Drug Deliv. Rev.56(11), 1649–1659 (2004).
  • Peres I , RochaS, Pereira MdC, Coelho M, Rangel M, Ivanova G: NMR structural analysis of epigallocatechin gallate loaded polysaccharide nanoparticles. Carbohydr. Polym.82(3) 861–866 (2010).
  • Hong J , LuH, MengX, Ryu J-H, Hara Y, Yang CS: Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res.62(24), 7241–7246 (2002).
  • Ju J , LuG, LambertJD, YangCS: Inhibition of carcinogenesis by tea constituents.Sem. Cancer Biol.17, 395–402 (2007).
  • Torchilin VP : Targeted pharmaceutical nanocarriers for cancer therapy and imaging.AAPS J.9(2), E128–E147 (2007).
  • Alonso MJ : Nanomedicines for overcoming biological barriers.Biomed. Pharmacother.58(3), 168–172 (2004).
  • Juzenas P , ChenW, SunYPet al.: Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.Adv. Drug Deliv. Rev.60(15), 1600–1614 (2008).
  • Shahidi F , Han X-Q: Encapsulation of food ingredients. Crit. Rev. Food Sci. Nutr.33(6), 501–547 (1993).
  • Picton L , BatailleI, MullerG: Analysis of a complex polysaccharide (gum arabic) by multi-angle laser light scattering coupled on-line to size exclusion chromatography and flow field flow fractionation.Carbohydr. Polym.42(1), 23–31 (2000).
  • Fang JY , HungCF, HwangTL, WongWW: Transdermal delivery of tea catechins by electrically assisted methods.Skin Pharmacol. Physiol.19, 28–37 (2005).
  • Storm G , BelliotSO, DaemenT, LasicDD: Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system.Adv. Drug Deliv. Rev.17(1), 31–48 (1995).
  • Berkland C , KingM, CoxA, KimK, PackDW: Precise control of plg microsphere size provides enhanced control of drug release rate.J. Control. Release82(1), 137–147 (2002).
  • Chung LY , CheungTC, KongSKet al.: Induction of apoptosis by green tea catechins in human prostate cancer du145 cells.Life Sci.68(10), 1207–1214 (2001).
  • Paschka AG , ButlerR, YoungCY: Induction of apoptosis in prostate cancer cell lines by the green tea component, (–)-epigallocatechin-3-gallate.Cancer Lett.130, 1–7 (1998).
  • Abd-Allah ARA , Al-MajedAA, MostafaAM, Al-ShabanahOA, El Din AG, Nagi MN: Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection. J. Biochem. Mol. Toxicol.16(5), 254–259 (2002).
  • Desai MP , LabhasetwarV, WalterE, LevyRJ, AmidonGL: The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.Pharm. Res.14(11), 1568–1573 (1997).
  • Rejman J , OberleV, ZuhornIS, HoekstraD: Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.Biochem. J.377(1), 159–169 (2004).
  • Yan F , ZhangC, ZhengYet al.: The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.Nanomed. Nanotechnol. Biol. Med.6(1), 170–178 (2010).
  • Zhang L , YuF, ColeAet al.: Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging.AAPS J.11(4), 693–699 (2009).
  • Qaddoumi M , UedaH, YangJ, DavdaJ, LabhasetwarV, LeeV: The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers.Pharm. Res.21(4), 641–648 (2004).
  • Fang JY , LeeWR, ShenSC, HuangYL: Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas.J. Dermatol. Sci.42(2), 101–109 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.